Neurolutions, Inc. is a medical device company developing a revolutionary platform of neurorehabilitation devices leveraging brain computer interface (BCI) technology. The company’s first product candidate, the IpsiHand Upper Extremity Rehabilitation System, or the IpsiHand System, is being developed for upper extremity rehabilitation in chronic stroke patients.
Looking for a particular Neurolutions employee's phone or email?
The Neurolutions annual revenue was $5.9 million in 2026.
Lauren Souders is the Vice President of Clinical Innovation and Clinical Affairs of Neurolutions.
8 people are employed at Neurolutions.
Neurolutions is based in Los Angeles, California.
The NAICS codes for Neurolutions are [541, 5414, 54, 54143].
The SIC codes for Neurolutions are [733, 73].